Protocol For Protein Expression And Purification

Reagents and chemicals

• Use an expression plasmid encoding the target protein with a His₆ tag or His₆-MBP tag, competent E. coli expression cells, selective antibiotic matched to the plasmid, LB or auto-induction medium, IPTG when using IPTG induction, imidazole for competitive elution from IMAC resin, NaCl and buffering salts for soluble extraction and chromatography, and SDS-PAGE reagents for monitoring expression and purification^{[1][3][4][5][9]}.

• Use lysozyme, DNase I, and Mg²⁺ only when enzymatic lysis/viscosity reduction is included, because published recombinant protein production workflows use cell disruption followed by clarification before affinity chromatography; omit protease inhibitors unless validated for the target and downstream assay^[4][9].

Antibodies, probes, dyes, or kits

• Use Coomassie-stained SDS-PAGE to detect target protein enrichment, and use Bradford or BCA protein assay reagents to quantify total protein concentration when compatible with buffer components^[10][11][12].

Cells, tissues, isolated organs, organoids, or animals

• Use an E. coli expression strain appropriate for the vector, commonly BL21(DE3)-type strains for T7-based expression; strains engineered to reduce IMAC-contaminating endogenous proteins may be considered when recurrent host-protein contamination is documented^[4][13].

Buffers and solutions

• Prepare lysis/binding buffer, wash buffer, and elution buffer with the same base buffer and salt composition, adding low imidazole to wash fractions and higher imidazole to elution fractions; exact imidazole concentrations should be optimized for each target because endogenous E. coli proteins can also bind IMAC resin^[1][13][14].

• For auto-induction, use literature-described auto-induction medium containing carbon sources that allow growth before lactose-dependent induction; for IPTG induction, use medium and induction conditions selected from a small-scale expression screen rather than assuming one universal condition^[5][6][7].

Equipment and instruments

• Use a shaking incubator for bacterial culture, refrigerated centrifuge for harvesting and lysate clarification, sonicator or homogenizer for lysis, chromatography column or FPLC system for IMAC, UV detector or spectrophotometer for protein absorbance, SDS-PAGE apparatus, and gel documentation system^[4][9][10].

Controls

• Include an uninduced culture or empty-vector lysate as a negative expression control, a soluble/insoluble fraction comparison after lysis, and a purification-process control such as flow-through, wash, and elution samples analyzed side-by-side by SDS-PAGE^[4][9][10].

Preparation Steps

• Transform the His-tagged expression plasmid into the chosen E. coli expression strain, select transformants on antibiotic-containing medium, and start a seed culture from a single colony or verified glycerol stock to maintain plasmid selection^[4][5][9].
• Prepare small-scale expression test cultures before scale-up, because published work shows that soluble yield depends on post-induction temperature, induction time, inducer concentration, growth phase, and the intrinsic properties of the target protein^[6][7][8].
• Prepare chromatography buffers before harvest and equilibrate the IMAC resin with binding buffer; reserve aliquots from total lysate, soluble supernatant, insoluble pellet, flow-through, wash, and elution fractions for SDS-PAGE analysis^{[1][4][9][10]}.

Operation Steps

• Grow expression cultures under antibiotic selection to the literature-supported induction point used for the chosen system: IPTG induction is commonly performed during logarithmic growth, whereas auto-induction cultures are inoculated and grown until carbon-source-regulated induction occurs automatically near high cell density^[5][6][7].
• Induce target expression using either IPTG or auto-induction; because no single induction condition is universal, screen temperature, induction time, and inducer concentration across a small matrix, prioritizing lower temperature and lower IPTG concentration when soluble expression is poor, as these variables have been reported to improve soluble recombinant protein yield for some proteins^[5][6][7][8].
• Harvest cells by centrifugation after the selected induction period, keep samples cold during downstream handling, and retain a small whole-cell sample for expression analysis by SDS-PAGE^[4][9][10].
• Resuspend the cell pellet in binding/lysis buffer and lyse by sonication or mechanical disruption; clarify lysate by refrigerated centrifugation and separately retain soluble supernatant and insoluble pellet samples to determine whether the target is soluble or present in inclusion bodies^[4][9][15].
• Load clarified soluble lysate onto equilibrated IMAC resin, collect the flow-through, wash the resin with wash buffer containing low imidazole, and elute His-tagged protein with higher imidazole; because endogenous E. coli proteins can co-purify on IMAC, analyze all fractions by SDS-PAGE and adjust wash/elution stringency only within conditions that preserve target binding^{[1][4][13][14]}.
• If the construct contains a His₆-MBP tag and a TEV protease site, purify the fusion protein first by IMAC, perform TEV cleavage under a condition validated for the construct, and separate cleaved tag, His-tagged TEV protease, and uncleaved fusion from the untagged target by a second IMAC step when required for downstream structural or functional studies^[3][16].
• If the target is mostly insoluble, do not proceed with native IMAC as a soluble-protein preparation; instead, document insolubility by soluble/pellet SDS-PAGE and either re-optimize expression conditions or use a literature-supported inclusion-body solubilization/refolding workflow only if appropriate for the target protein^{[6][7][8][15]}.
• Pool target-containing fractions based on SDS-PAGE purity, buffer-exchange or desalt to remove imidazole when needed for downstream assays, and concentrate only after confirming that concentration does not visibly precipitate the protein^[4][9].

Data Acquisition and Analysis

• Collect OD or culture-growth records, induction condition metadata, SDS-PAGE images of uninduced, induced, soluble, insoluble, flow-through, wash, and elution fractions, chromatograms if using FPLC, and protein concentration measurements from Bradford or BCA assays chosen for compatibility with the purification buffer^{[4][10][11][12]}.
• Quantify expression by comparing induced versus uninduced whole-cell samples, quantify solubility by comparing soluble and insoluble fractions, quantify purification by densitometry of SDS-PAGE bands or chromatographic peak integration, and normalize yield as milligrams of purified protein per liter of culture when culture volume and protein concentration are measured^[4][9][10].
• Use at least independent biological expression cultures when comparing induction conditions, and treat replicate purification fractions or assay wells as technical replicates; select the condition that maximizes soluble target protein at the expected molecular mass rather than total overexpression alone^[6][7][8].
• Interpret persistent co-eluting bands cautiously because native E. coli metal-binding proteins can bind IMAC resin; confirm identity of purified protein by expected molecular mass, Western blot against the tag when needed, peptide mass spectrometry, or target-specific functional assay when available^[10][13][14].

Problem: Target protein is mostly in the insoluble pellet

Possible Cause: Expression condition promotes aggregation or inclusion-body formation
Literature-supported Solution: Re-screen induction temperature, induction time, IPTG concentration, and growth phase; lower temperature and lower inducer concentration have improved soluble yield in published studies, but optimal values are target-dependent^[6][7][8].

Problem: High expression but low soluble recovery

Possible Cause: Target protein has poor intrinsic solubility in the E. coli cytoplasm
Literature-supported Solution: Test a solubility-enhancing fusion such as MBP or His₆-MBP when compatible with downstream use, because MBP fusions have been reported to improve soluble expression for difficult proteins^[3][17][18].

Problem: Many contaminant bands after IMAC

Possible Cause: Native E. coli proteins bind immobilized metal resin
Literature-supported Solution: Increase purification stringency within target-compatible limits, add a second polishing step, or use engineered strains designed to reduce IMAC-contaminating host proteins when contamination is reproducible^[13][14].

Problem: Eluted protein contains affinity tag that interferes with downstream work

Possible Cause: His or His-MBP tag remains attached
Literature-supported Solution: Include a validated TEV cleavage site and perform TEV protease digestion followed by a second IMAC step to remove His-tagged tag, His-tagged TEV protease, and uncleaved fusion when required^[3][16].

Problem: Protein assay gives unreliable concentration

Possible Cause: Buffer components interfere with dye- or copper-based assays
Literature-supported Solution: Choose Bradford or BCA only after checking compatibility with the sample buffer, because these assays rely on different chemistries and have different interference profiles^[11][12].